logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
L

Lizza Hendriks

maastricht university medical center

48H-index
432Paper Count
1.1WCitation Count
Published Papers 173
Publication Date
logo
Efficacy of Alectinib for ALK-positive NSCLC According to Tumor Burden and Body Mass Index: a Pooled Analysis of the Randomized Phase III Trials ALEX and J-ALEX
errEuropean Journal of Cancer
IF7.1
err2026-06-05
err0
errOAAI
errMarco Tagliamento; Marco Bruzzone; Eva Blondeaux; Filippo Dall’Olio; Mihaela Aldea; Carlo Genova; Arianna Marinello; Jordi Remon; Lizza E.L. Hendriks; Lucia Del Mastro; David Planchard; Fabrice Barlesi; Matteo Lambertini; Benjamin Besse
errShare
errSave
Model-Informed Approaches to Develop Drug Cost-Saving Dosing Strategies for Pembrolizumab
errEuropean Journal of Cancer
IF7.1
err2026-05-23
err0
errOAAI
errYan Wang; Laura H. Bukkems; Johan H.C. van Hasselt; Marie-Rose Crombag; Daphne Dumoulin; Jeroen J.M.A Hendrikx; Willemijn Theelen; Tom van der Hulle; Ellen Kapiteijn; Juliëtte Zwaveling; Annemarie Becker; Jeroen Hiltermann; Lizza E.L. Hendriks; Robin M.J.M. van Geel; Wouter H. van Geffen; Michel van den Heuvel; Thijs. H. Oude Munnink; Egbert F. Smit; Henk-Jan Guchelaar; Dirk Jan A.R. Moes
errShare
errSave
Antibody–Drug Conjugates in Non-small Cell Lung Cancer
errDrugs
IF14.4
err2026-05-18
err0
errOAAI
errLodovica Zullo; Martina Bortolot; Francesca R. Ogliari; Stephanie P. L. Saw; Robin van Geel; Rob ter Heine; Anna Sadowska; Jordi Remon; Lizza Hendriks
errShare
errSave
Upfront management of brain metastases in oncogene‑addicted NSCLC – An EORTC survey
errLung Cancer
IF4.4
err2026-05-09
err0
errOAAI
errAna Ortega-Franco; Ilias Houda; Mariana Brandão; Thomas Pierret; Lukas Käsmann; Niccolo Giaj-Levra; Jordi Remon; Thierry Berghmans; Anne-Marie C. Dingemans; Corinne Faivre-Finn; Lizza E.L. Hendriks
errShare
errSave
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD
errAnnals of Oncology
IF65.4
err2026-03-02
err0
PREAI
errJ.W. Riess; H.A. Yu; X. Le; A.J. de Langen; B.C. Cho; Z. Piotrowska; L.E.L. Hendriks; A. Morabito; L. Bonanno; O.T. Brustugun; T.O. Halvorsen; Y.J. Kim; K.A. Marrone; Y. Shiraishi; J.W. Goldman; H. Ambrose; P.E. Smith; P.G. FraenkeI; K.H. Tang; J.M. Lehman
errShare
errSave
Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatment
errLung Cancer
IF4.4
err2026-02-16
err0
errOAAI
errValentina Bartolomeo; Mandy Jongbloed; Jarno W.J. Huijs; Andrea Riccardo Filippi; Ben E.E.M. van den Borne; Cordula Pitz; Hester Gietema; Juliette Degens; Magdolen Youssef-El Soud; Michelle Steens; Safiye Dursun; Wouter H. van Geffen; Peter de Boer; Dirk K.M. De Ruysscher; Lizza E.L. Hendriks
errShare
errSave
Automated CT-derived Body Composition Predicts Pathologic Response to Neoadjuvant Immunotherapy in Non–Small Cell Lung Cancer
errCancer Letters
IF10.1
err2026-01-06
err0
errOAAI
errYilong Huang; Zhitao Wei; Guanchao Ye; Yanfen Cui; Chuanpu Li; Guangyao Wu; Wei Yang; Bingqian Zhang; Zhenguang Zhang; Yuanming Jiang; Lizza E.L. Hendriks; Leonard Wee; Dirk De Ruysscher; Andre Dekker; Lei Shi; Zaiyi Liu; Bo He; Zhenwei Shi
errShare
errSave
Effect of treatment sequencing on outcome of patients with non-small cell lung cancer with a synchronous solitary extrathoracic metastasis
errLung Cancer
IF4.4
err2025-12-25
err0
errOAAI
errMandy Jongbloed; Ronald A.M. Damhuis; Wouter H. Van Geffen; Peter de Boer; Jarno W.J. Huijs; Safiye Dursun; Juliette Degens; Ben E.E.M. van den Borne; Magdolen Youssef-El Soud; Michelle Steens; Cordula Pitz; Dirk K.M. De Ruysscher; Lizza E.L. Hendriks
errShare
errSave
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50%
errESMO Open
IF8.3
err2025-11-17
err0
errOAAI
errA. De Giglio; L. Zullo; A. Di Federico; M. Cani; M. Aldea; D. Soldato; F.G. Dall’Olio; F. Mantuano; F. Sperandi; V. Favorito; A. Sadowska; L.E.L. Hendriks; T. Gorria; L. Mezquita; F. Tabbò; S. Novello; F. Gelsomino; B. Besse; A. Ardizzoni
errShare
errSave
Optimizing lazertinib therapy through GSTM1 genotyping: a strategy to reduce excess drug exposure and potential toxicity
errCancer Chemotherapy and Pharmacology
IF2.3
err2025-11-07
err0
errOAAI
errRob ter Heine; Bianca J. C. van den Bosch; Robin M. van Geel; Wouter H. van Geffen; Lizza E. L. Hendriks; Michel M. van den Heuvel; Simon E. Koele; Adrianus J. de Langen; Thijs H. Oude Munnink; Anthonie J. van der Wekken
errShare
errSave
Improved survival and rising incidence: insights from the largest retrospective study on leptomeningeal metastases in patients with NSCLC
errAnnals of Oncology
IF65.4
err2025-10-20
err0
PREAI
errJ.W.J. Huijs; E. Le Rhun; L.E.L. Hendriks
errShare
errSave
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group
errLung Cancer
IF4.4
err2025-10-14
err0
PREAI
errMariana Brandão; Elena Prisciandaro; Eleni Xenophontos; Alessio Mariolo; Amir H. Sadeghi; Andrea R. Filippi; Antonin Levy; Artur Bandura; Caroline Caramella; Chris Dickhoff; Constance de Margerie-Mellon; Corinne Faivre-Finn; Daniel Portik; David Sanchez-Lorente; Dirk De Ruysscher; Egbert Smit; Elisa Gobbini; Elie Fadel; Enrico Ruffini; Emanuela Olmetto; Francesco Cortiula; Idris Bahce; Ilias Houda; Isabelle Opitz; Jarushka Naidoo; John Edwards; Jordi Remon; José Carlos Benitez; Juan Carlos Trujillo; Jules Derks; Karim Amrane; Koen J. Hartemink; Konstantinos Stathopoulos; Lizza E.L. Hendriks; Manoli Iglesias; Mario Occhipinti; Matthias Guckenberger; Niccolo Giaj Levra; Nicolas Girard; Noemi Reguart; Olaf Mercier; Paolo Bironzo; Paul Hofman; René Horsleben Petersen; Riccardo De Angelis; Ronan Abgral; Safae Terrisse; Sanjay Popat; Thomas Pierret; Torsten Gerriet Blum; Umberto Ricardi; Valeria Dionisi; Thierry Berghmans; Anne-Marie C. Dingemans
errShare
errSave
Association of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) with survival in patients with oligometastatic non-small-cell lung cancer treated with immunotherapy: a multicentre retrospective study
errEuropean Journal of Nuclear Medicine and Molecular Imaging
IF7.6
err2025-10-10
err0
PREAI
errFrancesca Rita Ogliari; Mandy Jongbloed; Rianne D. W. Vaes; Ruud M. A. Houben; Valentina Bartolomeo; Ben E. E. M. van den Borne; Juliette Degens; Jarno W. J. Huijs; Cordula Pitz; Michelle Steens; Magdolen Youssef-El Soud; Martina Sollini; Dirk K. M. De Ruysscher; Cristina Mitea; Lizza E. L. Hendriks
errShare
errSave
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
errNature Reviews Clinical Oncology
IF82.2
err2025-10-09
err0
PREAI
errJordi Remon; Antonin Levy; Romane Gille; Isabelle Martel-Lafay; Martina Bortolot; Lizza E. L. Hendriks; Corinne Faivre-Finn; Natasha Leighl; Martin Reck; Maurice Pérol
errShare
errSave
AI-derived longitudinal and multi-dimensional CT classifier for non-small cell lung cancer to optimize neoadjuvant chemoimmunotherapy decision: a multicentre retrospective study
erreClinicalMedicine
IF10
err2025-10-07
err0
errOAAI
errGuanchao Ye; Zhitao Wei; Chu Han; Guangyao Wu; Chinting Wong; Yanting Liang; Xiaobo Chen; Wang Zhou; Jianbo Gao; Changhong Liang; Yongde Liao; Lizza E.L. Hendriks; Leonard Wee; Dirk De Ruysscher; Andre Dekker; Haiyu Zhou; Yu Qi; Zaiyi Liu; Zhenwei Shi
errShare
errSave
Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer Registry
errLUNG CANCER
IF4.4
err2025-10-01
err0
errOAAI
errHuijs, Jarno W. J.; Ogliari, Francesca R.; Damhuis, Ronald A. M.; Jongbloed, Mandy; Broen, Martinus P. G.; Anten, Monique H. M. E.; Brandsma, Dieta; Degens, Juliette H. R. J.; De Ruysscher, Dirk K. M.; Hendriks, Lizza E. L.
errShare
errSave
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study
errLung Cancer
IF4.4
err2025-09-28
err0
PREAI
errJ.W.T. van der Wel; S.M. Ernst; M. Jebbink; D. van den Broek; S.K. Badrising; L.C. Steinbusch; G. Ruiter; W.S.M.E. Theelen; B.A.M.H. van Veggel; J. Smit; A.M. Dingemans; M.S. Paats; H.J. Dubbink; S.M.S. Hashemi; T. Radonic; D. Cohen; A.J. van der Wekken; A. ter Elst; W. Timens; L.E. Hendriks; E.J.M. Speel; M.M.J. Disselhorst; A. Welling; F. van der Meer; L.J.W. Bosch; K. Monkhorst; M.C. Boelens; E.F. Smit; A.J. de Langen
errShare
errSave
Rethinking immunotherapy in patients with SCLC with poor performance status
errThe Lancet Respiratory Medicine
IF32.8
err2025-09-28
err0
PREAI
errNoemi Reguart; Lizza E L Hendriks
errShare
errSave
Can the positive findings from POD1UM-304 improve patient care worldwide?
errThe Lancet Respiratory Medicine
IF0
err2025-09-19
err0
PREAI
errFrancesca R Ogliari; Jessica Menis; Lizza E L Hendriks
errShare
errSave
Clinical risk factors for developing brain metastases during first-line (chemo-)immunotherapy in patients with non-small cell lung cancer without known baseline brain metastases
errLung Cancer
IF4.4
err2025-09-02
err0
errOAAI
errJarno W.J. Huijs; Anna M. Sadowska; Juliette H.R.J. Degens; Christi M.J. Steendam; Frederike Bensch; Lucie B.M. Hijmering-Kappelle; Tom M.T. de Schrevel; Wouter H. van Geffen; Magdolen Youssef-El Soud; Michelle M.H. Steens; Cordula Pitz; Dirk K.M. De Ruysscher; Lizza E.L. Hendriks
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Michael Weller
H-index: 175 · Papers: 2.8K
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
I
Ignacio I. Wistuba
H-index: 153 · Papers: 2.8K
T
Tony Mok
H-index: 131 · Papers: 1.1K
J
John V. Heymach
H-index: 128 · Papers: 2.4K
View more